In lung cancer, a study reported that HIF1A could mediate the immunosuppressive by the HIF1A/LOXL2/EMT pathways, and our results also showed that COPZ1 had a positive correlation with HIF1A, LOXL2 and EMT [37]. Here, LOXL2 is linked to lung cancer.